Viridian Therapeutics, Inc.\DE - FORM 10-K - EX-21.1 - EXHIBIT 21.1 - March 14, 2018

Attached files

file	filename
10-K - 10-K - Viridian Therapeutics, Inc.\DE	mgen-12312017x10k.htm
EX-32.1 - EXHIBIT 32.1 - Viridian Therapeutics, Inc.\DE	mgen-12312017xex321.htm
EX-23.1 - EXHIBIT 23.1 - Viridian Therapeutics, Inc.\DE	mgen-12312017xex231.htm
EX-31.1 - EXHIBIT 31.1 - Viridian Therapeutics, Inc.\DE	mgen-12312017xex311.htm
EX-4.2 - EXHIBIT 4.2 - Viridian Therapeutics, Inc.\DE	mgen-12312017xex42new.htm
EX-31.2 - EXHIBIT 31.2 - Viridian Therapeutics, Inc.\DE	mgen-12312017xex312.htm

Exhibit 21.1

Subsidiaries of the Registrant

(as of March 15, 2018)



Name of Subsidiary	Jurisdiction of Incorporation

Miragen Therapeutics Europe Limited	England and Wales